Safdar A*, Torres I, Cleeland C, Rolston K. Antimicrobial availability for oncology patients with advanced malignancy in Latin America: WHO/PAHO Medical Oncology Survey Report 2000-2002. Abstract # 055. The 13th European Congress of Clinical Microbiology and Infectious Diseases. Prague, Czech Republic. May 1–4, 2004. Clinical Microbiology and Infection. 2004. ORAL PRESENTATION

/in /by

Hogan H, Chemaly RF, Coyle E, Kamana M, Kontoyiannis DP, Safdar A, Bodey GP, Raad II. Early combination antiviral therapy for cytomegalovirus infection in patients with hematological malignancies. Abstract # 364. The 41st Annual Meeting of Infectious Diseases Society of America. San Diego, CA. October 9–12, 2003. Clin Infect Dis2003

/in /by

Chemaly RF, Procop GW, Safdar A, Avery RK, Yen-Lieberman B. The clinical significance of HHV-6 and HCMV pulmonary [bronchoalveolar lavage (BAL)] reactivation in recipient of lung transplantation. Abstract # 363. The 41st Annual Meeting of Infectious Diseases Society of America. San Diego, CA. October 9 – 12, 2003. Clin Infect Dis 2003

/in /by

Safdar A*, Talwani R, Bryan CS. Vancomycin-resistant Enterococcus: favorable impact of targeted infection control measures on the rising prevalence of nosocomial pathogens. The 40th Annual Meeting of the Infectious Diseases Society of America. Chicago, October 24–27, 2002. Clin Infect Dis 2002.

/in /by

Abraham CJ, Park S, Koll B, Raucher B, Motyl M, Safdar A, Chaturvedi V, Perlin DS. Azole resistance in Candida glabrata. The 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Chicago, IL. December 51-19, 2001.

/in /by

Talwani R, Horvath JA, Safdar A. Reversible hepatitis: a serious concern in patients on combination AmBisome and intravenous itraconazole for refractory systemic mycoses. The 39th Annual Meeting of the Infectious Diseases Society of America (IDSA). San Francisco, California. October 25-28, 2001. Clin Infect Dis 2001; 33: 1199.

/in /by

Safdar A*, Papadopoulous EB, Armstrong D. Acute cytomegalovirus reactivation following allogeneic blood or marrow transplantation and risk of systemic listeriosis. The 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, California. October 25-28, 2001. Clin Infect Dis 2001;33:1163.

/in /by

Safdar A*, Bruorton M, Bannister T, Henslee-Downey JP, Van Rhee F. Predictors of antiviral response in high-risk marrow transplantation recipients with cytomegalovirus reactivation. The 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, California. October 25-28, 2001. Clin InfectDis 2001;33:1163.

/in /by

Safdar A*, Perlin D, Armstrong D. Impact of Candida species colonization on mortality in patients with cancer. The 11th European Congress of Clinical Microbiology and Infectious Diseases. Istanbul, Turkey. April 1-4, 2001. ClinMicrobiol Infect 2001; 7(Suppl1): S336.

/in /by

Safdar A*, Armstrong D. Predominant 1/2 serotype associated with listeriosis in patients with underlying malignancy in United States. Abstract # 1092. The 11th European Congress of Clinical Microbiology and Infectious Diseases. Istanbul, Turkey. April 1–4, 2001. ClinMicrobiol Infect 2001; 7(Suppl1): S224–225.

/in /by